Trial no.:
|
PACTR202005715810295 |
Date of Approval:
|
07/05/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy of mulligan SNAGs on cervical muscle activity in patients with chronic mechanical neck pain (randomized clinical trial) |
Official scientific title |
Efficacy of mulligan SNAGs on cervical muscle activity, pain and function in patients with chronic mechanical neck pain (randomized clinical trial) |
Brief summary describing the background
and objectives of the trial
|
Neck pain is a frequent complaint, more so in women than in men (Fejer et al., 2006). The lifetime preva- lence of neck pain varies between 43% and 66.7% (Bovim et al., 1994; Côté et al., 1998, 2004; Guez
et al., 2002; Chiu and Leung, 2006), and with a point prevalence of ~20% (Côté et al., 1998), it is one of the most frequent musculoskeletal complaints (Picavet and Schouten, 2003). Effective treatment of neck pain is essential; however, in most cases, the structural source of pain cannot be identified. Consequently, a reasonable pharmacological or surgical treatment can rarely be offered (Bogduk and McGuirk, 2006). Many patients seek ongoing conservative management from a variety of health care practitioners (Freburger et al., 2005). Mulligan pioneered specific manual approach called mobilization with movement (MWM).The advance of this approach was aimed for application on the spinal joints. The most commonly used Mulligan technique is called “sustained natural apophyseal glides” or SNAGs, this technique has introduced in 1999 by Mulligan and is per- formed by applying an accessory glide along the axis of the facet joint of the affected level while the patient is doing an active movement from weight-bearing position(Konstantinou et al., 2007).
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
SNAGs |
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/06/2020 |
Actual trial start date |
01/06/2020 |
Anticipated date of last follow up |
01/08/2020 |
Actual Last follow-up date |
01/08/2020 |
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Completed |
Publication URL |
|
|